Background
Background A number of studies have A number of studies have examined the prevalence of diabetes examined the prevalence of diabetes mellitus and impaired glucose tolerance in mellitus and impaired glucose tolerance in general populations and in those with general populations and in those with schizophrenia and other forms of serious schizophrenia and other forms of serious mental illness. mental illness.
Aims Aims To establish whether it is possible
To establish whether it is possible to describe accurately comparative rates to describe accurately comparative rates of diabetes mellitus and impaired glucose of diabetes mellitus and impaired glucose tolerance in populations of people with tolerance in populations of people with schizophrenia and those without mental schizophrenia and those without mental illness. illness.
Method
Method Review of current literature.
Review of current literature.
Results
Results Research published in the preResearch published in the preneuroleptic era suggested that people neuroleptic era suggested that people with severe mental illness were at with severe mental illness were at increased risk of developing glycaemic increased risk of developing glycaemic abnormalities.Recent studies appear to abnormalities.Recent studies appear to confirm thatthe prevalence of diabetes confirm thatthe prevalence of diabetes and impaired glucose tolerance may be and impaired glucose tolerance may be higher in people with schizophrenia than in higherin people with schizophrenia than in the general population, and suggestthat the general population, and suggestthat patients with schizophrenia have impaired patients with schizophrenia have impaired glucose tolerance even before they begin glucose tolerance even before they begin treatment. treatment.
Conclusions
Conclusions Schizophrenia may be a Schizophrenia may be a significant and independent risk factor for significant and independent risk factor for both diabetes and impaired glucose both diabetes and impaired glucose tolerance.Current data preclude precise tolerance.Current data preclude precise estimates of the prevalence of these estimates of the prevalence of these conditions among people with conditions among people with schizophrenia. schizophrenia.
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The question of whether people with The question of whether people with schizophrenia are at greater risk of developschizophrenia are at greater risk of developing type 2 diabetes than the general popuing type 2 diabetes than the general population has been puzzling researchers and lation has been puzzling researchers and clinicians since the early 1900s -long before clinicians since the early 1900s -long before the introduction of antipsychotic medicathe introduction of antipsychotic medications. As far back as 1897, the eminent tions. As far back as 1897, the eminent Victorian psychiatrist Henry Maudsley Victorian psychiatrist Henry Maudsley noted, 'Diabetes is a disease noted, 'Diabetes is a disease which often shows itself in families in which often shows itself in families in which insanity prevails ' (Maudsley, 1979) . which insanity prevails ' (Maudsley, 1979) . More than a century later, and after inMore than a century later, and after increasingly sophisticated research into the creasingly sophisticated research into the issue, Maudsley's intuitive observations issue, Maudsley's intuitive observations about the association between severe psychabout the association between severe psychiatric disorders and diabetes still appear to iatric disorders and diabetes still appear to hold true. hold true.
Although early naturalistic approaches Although early naturalistic approaches to the study of diabetes in patients with to the study of diabetes in patients with severe mental illness provided clues that severe mental illness provided clues that an association did exist, it has been the an association did exist, it has been the more recent cross-sectional epidemiological more recent cross-sectional epidemiological studies assessing the prevalence of diabetes studies assessing the prevalence of diabetes in populations of people with schizophrenia in populations of people with schizophrenia that have established beyond reasonable that have established beyond reasonable doubt that such people are at increased doubt that such people are at increased risk of developing diabetes, and that schizorisk of developing diabetes, and that schizophrenia should now be considered to be an phrenia should now be considered to be an independent risk factor for the condition. independent risk factor for the condition.
METHOD METHOD
Review of current literature. Review of current literature.
Confirming the association: Confirming the association: research challenges research challenges Studies in the pre-neuroleptic era clearly Studies in the pre-neuroleptic era clearly suggested that schizophrenia might be a risk suggested that schizophrenia might be a risk factor for the development of diabetes (Kooy, factor for the development of diabetes (Kooy, 1919; Lorenz, 1922; Henry & Mangan, 1919; Lorenz, 1922; Henry & Mangan, 1925; Freeman 1925; Freeman et al et al, 1944; Braceland , 1944; Braceland et al et al, , 1945; Freeman, 1946) . However, many dif-1945; Freeman, 1946) . However, many different criteria were used to define both ferent criteria were used to define both schizophrenia and diabetes mellitus in these schizophrenia and diabetes mellitus in these studies, and the 'pre-diabetic' state of imstudies, and the 'pre-diabetic' state of impaired glucose tolerance has only relatively paired glucose tolerance has only relatively recently been defined (World Health recently been defined (World Health Organization, 1999) . Today, standardOrganization, 1999). Today, standardis isation of criteria for the diagnosis of ation of criteria for the diagnosis of diabetes, diabetes, impaired glucose tolerance and impaired glucose tolerance and schizophrenia make accurate and reproschizophrenia make accurate and reproducible diagnoses possible, and allow ducible diagnoses possible, and allow epidemiological comparisons to be made epidemiological comparisons to be made across populations. across populations.
In order to establish definitively an In order to establish definitively an association between schizophrenia and diaassociation between schizophrenia and diabetes, it would be necessary for researchers betes, it would be necessary for researchers to show that the prevalence of diabetes is to show that the prevalence of diabetes is higher among people with schizophrenia higher among people with schizophrenia than in reference populations using modern than in reference populations using modern research techniques and standardised disresearch techniques and standardised disease definitions. Unfortunately, establishing ease definitions. Unfortunately, establishing the true prevalence of impaired glucose the true prevalence of impaired glucose tolerance and/or diabetes in any population tolerance and/or diabetes in any population is fraught with difficulty. Diabetes has a is fraught with difficulty. Diabetes has a gradual and insidious onset and is fregradual and insidious onset and is frequently asymptomatic, thereby explaining quently asymptomatic, thereby explaining in part why up to half of all individuals in part why up to half of all individuals with diabetes are thought to remain undiagwith diabetes are thought to remain undiagnosed in the community (Harris nosed in the community (Harris et al et al, 1987; , 1987; Mykkanen Mykkä nen et al et al, 1990; Harris, 1993 Harris, ). , 1990 Harris, 1993 ). Prospective population-based studies in Prospective population-based studies in which there is universal screening for which there is universal screening for impaired glucose tolerance and diabetes impaired glucose tolerance and diabetes using recommended blood glucose testing using recommended blood glucose testing methods and established diagnostic criteria methods and established diagnostic criteria (World Health Organization, 1999) provide (World Health Organization, 1999) provide the best estimates of diabetes prevalence in the best estimates of diabetes prevalence in the general population. Unfortunately, few the general population. Unfortunately, few such studies have ever been conducted, such studies have ever been conducted, and because of the marked differences in and because of the marked differences in diabetes rates between countries, social diabetes rates between countries, social classes and age groups, it is difficult to classes and age groups, it is difficult to extrapolate their estimates to other populaextrapolate their estimates to other populations. Establishing the true prevalence of tions. Establishing the true prevalence of impaired glucose tolerance and diabetes in impaired glucose tolerance and diabetes in patients with schizophrenia is even more patients with schizophrenia is even more challenging. Difficulties with the identificachallenging. Difficulties with the identification and diagnosis of patients with diabetes tion and diagnosis of patients with diabetes are further compounded by inconsistencies are further compounded by inconsistencies in the diagnosis of schizophrenia. Some in the diagnosis of schizophrenia. Some diabetes prevalence studies such as that by diabetes prevalence studies such as that by Cohen Cohen et al et al (2003) have evaluated hetero-(2003) have evaluated heterogeneous populations that have included geneous populations that have included individuals with schizoaffective disorder, individuals with schizoaffective disorder, bipolar disorder and personality disorders, bipolar disorder and personality disorders, as well as those with schizophrenia, and as well as those with schizophrenia, and although these studies provide much valualthough these studies provide much valuable information, they must be interpreted able information, they must be interpreted with care, since diabetes prevalence estiwith care, since diabetes prevalence estimates do differ between these mates do differ between these psychiatric psychiatric conditions (Regenold conditions (Regenold et al et al, 2002) . , 2002). Patients with schizophrenia are often Patients with schizophrenia are often reluctant to give consent to participate in reluctant to give consent to participate in epidemiological studies -especially ones epidemiological studies -especially ones that require blood samples to be taken that require blood samples to be taken (Cohen (Cohen et al et al, 2003) . This may result in , 2003) . This may result in s 6 7 s 6 7 
RESULTS RESULTS
Prevalence of diabetes Prevalence of diabetes in the general population in the general population Notwithstanding the methodological chalNotwithstanding the methodological challenges outlined above, it is now clear that lenges outlined above, it is now clear that the prevalence of diabetes in the general the prevalence of diabetes in the general population is high and increasing year by population is high and increasing year by year (Mokdad year (Mokdad et al et al, 2001) . Studies in the , 2001). Studies in the USA have found rates of known diabetes USA have found rates of known diabetes in the general population of between in the general population of between 1.2% (for people aged 18-44 years) and 1.2% (for people aged 18-44 years) and 6.3% (for people aged 45-64 years) 6.3% (for people aged 45-64 years) , with the highest , with the highest prevalence rates reported in African prevalence rates reported in African Americans, Native Americans and Mexican Americans, Native Americans and Mexican Americans Americans (Adams & Marano, 1995; Harris, 1998) . Harris, 1998 Health, 1998) show prevalence rates of diaHealth, 1998) show prevalence rates of diabetes to be around 5% and 9%, respecbetes to be around 5% and 9%, respectively, and confirm that twice as many tively, and confirm that twice as many people in the general population may have people in the general population may have impaired glucose tolerance as have diabetes. impaired glucose tolerance as have diabetes.
Prevalence of diabetes Prevalence of diabetes in schizophrenia in schizophrenia
Studies assessing the prevalence of type 2 Studies assessing the prevalence of type 2 diabetes in people with schizophrenia diabetes in people with schizophrenia broadly agree that the condition may be broadly agree that the condition may be at least two to four times more prevalent at least two to four times more prevalent than in the general population (Keskiner than in the general population (Keskiner et al et al, 1973; Mukherjee , 1973; Mukherjee et al et al, 1996; Dixon , 1996; Dixon et al et al, 2000; Sernyak , 2000; Sernyak et al et al, 2002; Lindenmayer , 2002; Lindenmayer et al et al, 2003; Subramaniam , 2003; Subramaniam et al et al, 2003) . , 2003). There is, however, significant variability There is, however, significant variability in the reported prevalence rates from differin the reported prevalence rates from different studies. One major confounder when ent studies. One major confounder when attempting to establish a true prevalence attempting to establish a true prevalence figure in schizophrenia and other populafigure in schizophrenia and other populations is the number of people who have tions is the number of people who have been actively screened. Citrome been actively screened. Citrome et al et al (2003) have recently reported that, in a ret-(2003) have recently reported that, in a retrospective epidemiological study evaluating rospective epidemiological study evaluating the incidence of newly diagnosed diabetes the incidence of newly diagnosed diabetes mellitus in patients commencing antimellitus in patients commencing antipsychotic treatment, some of the apparent psychotic treatment, some of the apparent differences in risk between individual differences in risk between individual agents could be attributed to the greater agents could be attributed to the greater degree of glucose monitoring in patients degree of glucose monitoring in patients receiving clozapine compared with those receiving clozapine compared with those receiving other antipsychotics. receiving other antipsychotics.
Another important factor that might Another important factor that might influence prevalence figures reported in influence prevalence figures reported in schizophrenia studies is the design of the schizophrenia studies is the design of the study. Some studies require glucose screenstudy. Some studies require glucose screening (and possible exclusion for glycaemic ing (and possible exclusion for glycaemic abnormalities) prior to patient enrolment; abnormalities) prior to patient enrolment; others are cross-sectional in nature. In the others are cross-sectional in nature. In the latter case, all known confounders (such latter case, all known confounders (such as population age, ethnicity and geography) as population age, ethnicity and geography) must be accounted for. Even the year of the must be accounted for. Even the year of the study and the type of schizophrenia diagstudy and the type of schizophrenia diagnosed in the patients enrolled may affect nosed in the patients enrolled may affect prevalence estimates. In 2003, for example, prevalence estimates. In 2003, for example, improved awareness of the possibility of improved awareness of the possibility of blood glucose abnormalities meant that blood glucose abnormalities meant that more patients taking antipsychotic medicamore patients taking antipsychotic medications might have been screened for diabetes, tions might have been screened for diabetes, which might account for the apparently which might account for the apparently higher prevalence rates being reported higher prevalence rates being reported compared with 10 years ago. compared with 10 years ago.
Patients with treatment-resistant schizoPatients with treatment-resistant schizophrenia may be more likely to be screened phrenia may be more likely to be screened for glucose abnormalities than other people for glucose abnormalities than other people with schizophrenia, and those that showed with schizophrenia, and those that showed positive would probably be excluded from positive would probably be excluded from prevalence trials, a fact illustrated clearly prevalence trials, a fact illustrated clearly by Lindenmayer by Lindenmayer et al et al (2003) , who found a (2003), who found a prevalence of diabetes mellitus of only 7% prevalence of diabetes mellitus of only 7% in their cohort of patients with treatmentin their cohort of patients with treatmentresistant schizophrenia prior to study entry. resistant schizophrenia prior to study entry.
Mukherjee Mukherjee et al et al (1996) found an overall (1996) found an overall prevalence of known diabetes of 15.8% in prevalence of known diabetes of 15.8% in a cohort of patients with schizophrenia a cohort of patients with schizophrenia admitted to a long-term care facility in admitted to a long-term care facility in Italy; diabetes was significantly more comItaly; diabetes was significantly more common in patients not receiving antipsychotics mon in patients not receiving antipsychotics than in those who were. This overall prevathan in those who were. This overall prevalence rate is substantially higher than the lence rate is substantially higher than the known prevalence of diabetes in the general known prevalence of diabetes in the general population of Italy, which is estimated to population of Italy, which is estimated to be 2-3% (Verrillo be 2-3% (Verrillo et al et al, 1985; Bruno , 1985; Bruno et al et al, , 1992) . The prevalence of known diabetes 1992). The prevalence of known diabetes in Mukherjee's patient cohort increased in Mukherjee's patient cohort increased with age, from 0% in individuals younger with age, from 0% in individuals younger than 50 years, to 12.9% in the 50-59 years than 50 years, to 12.9% in the 50-59 years age group, and to 18.9% in the 60-69 years age group, and to 18.9% in the 60-69 years age group (Mukherjee age group (Mukherjee et al et al, 1996) . The , 1996) . The prevalence of diabetes decreased to 16.7% prevalence of diabetes decreased to 16.7% in patients aged 70-74 years and to 9.4% in patients aged 70-74 years and to 9.4% in those aged over 75 years, which has been in those aged over 75 years, which has been interpreted by the investigators to indicate interpreted by the investigators to indicate selective mortality due to coronary heart selective mortality due to coronary heart disease (Mukherjee disease (Mukherjee et al et al, 1996) . , 1996 (PORT) in the USA to assess the prevalence and in the USA to assess the prevalence and clinical correlates of known diabetes in this clinical correlates of known diabetes in this population. Much of the data were population. Much of the data were collected before the widespread use of collected before the widespread use of novel antipsychotic medications. The lifenovel antipsychotic medications. The lifetime prevalence of known diabetes reported time prevalence of known diabetes reported for the people with schizophrenia in this for the people with schizophrenia in this study was 15%, with increasing age, being study was 15%, with increasing age, being female and being of African American or female and being of African American or 'other' non-White racial origin increasing 'other' non-White racial origin increasing the likelihood of having diabetes (Dixon the likelihood of having diabetes (Dixon et al et al, 2000) . The 15% prevalence of dia-, 2000) . The 15% prevalence of diabetes found in this study far exceeded rates betes found in this study far exceeded rates typically reported in age-matched general typically reported in age-matched general populations, but this probably reflects the populations, but this probably reflects the exhaustive interviewing techniques used in exhaustive interviewing techniques used in the study. the study.
Sernyak Sernyak et al et al (2002) reported an (2002) reported an overall prevalence of diagnosed diabetes overall prevalence of diagnosed diabetes of 18% in a large sample of people with of 18% in a large sample of people with schizophrenia being treated as out-patients schizophrenia being treated as out-patients (2003) conducted a chart review of 607 people with schizochart review of 607 people with schizophrenia resident in a long-stay ward in phrenia resident in a long-stay ward in Singapore. None of the patients had received Singapore. None of the patients had received atypical antipsychotic medication either in atypical antipsychotic medication either in the past or at the time of the study. A prevthe past or at the time of the study. A prevalence of known diabetes of 4.9% was alence of known diabetes of 4.9% was reported, and patients with this diagnosis reported, and patients with this diagnosis were excluded from further study. Inwere excluded from further study. Informed consent was then obtained to screen formed consent was then obtained to screen 194 of the remaining patients, and 16% of 194 of the remaining patients, and 16% of these were found to have diabetes, taking these were found to have diabetes, taking the total diabetes prevalence rate to around the total diabetes prevalence rate to around 21%. Prevalence rates were found to be 21%. Prevalence rates were found to be double those seen in the general population double those seen in the general population of Singapore in patients under the age of 60 of Singapore in patients under the age of 60 years (Table 1) , but lower than the general years (Table 1) , but lower than the general population in those aged 60 years and population in those aged 60 years and above. In this study, the highest rate of above. In this study, the highest rate of diabetes (50%) was found in patients aged diabetes (50%) was found in patients aged 50-59 years (Subramaniam 50-59 years (Subramaniam et al et al, 2003) . , 2003). Gupta Gupta et al et al (2003) reported a prevalence (2003) reported a prevalence rate of 17% for diabetes in a chart review rate of 17% for diabetes in a chart review of 208 patients with psychotic disorders of 208 patients with psychotic disorders who were receiving antipsychotic mediwho were receiving antipsychotic medication. Fasting blood glucose levels were cation. Fasting blood glucose levels were used to establish the diagnosis of diabetes used to establish the diagnosis of diabetes in this study (Gupta in this study (Gupta et al et al, 2003) . , 2003). Subramaniam Subramaniam et al et al (2003) report the (2003) report the prevalence of impaired glucose tolerance prevalence of impaired glucose tolerance in people with schizophrenia is less well in people with schizophrenia is less well defined, but screening studies suggest that defined, but screening studies suggest that it may be almost twice as high as the prevait may be almost twice as high as the prevalence of diabetes. In their screening study, lence of diabetes. In their screening study, the overall prevalence of diabetes was the overall prevalence of diabetes was found to be 21% but that of impaired found to be 21% but that of impaired glucose tolerance was 31%. The study has glucose tolerance was 31%. The study has also highlighted the substantial problem of also highlighted the substantial problem of underrecognition of diabetes and impaired underrecognition of diabetes and impaired glucose tolerance in people with schizoglucose tolerance in people with schizophrenia. Although 21% of patients were phrenia. Although 21% of patients were identified as having diabetes once they were identified as having diabetes once they were actively screened, only 4.9% of patients actively screened, only 4.9% of patients had previously received a diagnosis (Subrahad previously received a diagnosis (Subra- 2003) . Another study (Cohn , 2003) . Another study (Cohn et al et al, 2002) found that active screening for , 2002) found that active screening for impaired glucose tolerance and diabetes in impaired glucose tolerance and diabetes in another cohort of 153 patients who had another cohort of 153 patients who had been taking antipsychotic monotherapy been taking antipsychotic monotherapy for at least 3 months found that 31% of for at least 3 months found that 31% of individuals had either diabetes or impaired individuals had either diabetes or impaired glucose tolerance, and that in the majority glucose tolerance, and that in the majority (67%) the condition was previously un-(67%) the condition was previously unidentified (Cohn identified (Cohn et al et al, 2002 Ryan and colleagues reported results Ryan and colleagues reported results from a landmark study involving young from a landmark study involving young (mean age 33.6 years) patients with first-(mean age 33.6 years) patients with firstepisode episode schizophrenia. All patients were schizophrenia. All patients were drug-naıve, drug-naïve, allowing a separation of the allowing a separation of the effects of the disease from the potential effects of the disease from the potential confounding effects of any antipsychotic confounding effects of any antipsychotic medication. Despite being young and never medication. Despite being young and never having been exposed to neuroleptics, more having been exposed to neuroleptics, more than 15% of the individuals in this study than 15% of the individuals in this study had already developed impaired fasting had already developed impaired fasting glucose tolerance, compared with none of glucose tolerance, compared with none of the matched healthy control groups (Ryan the matched healthy control groups (Ryan et al et al, 2003) . This provides some of the , 2003). This provides some of the clearest evidence that schizophrenia itself clearest evidence that schizophrenia itself may be an independent risk factor for immay be an independent risk factor for impaired glucose tolerance, which is a known paired glucose tolerance, which is a known risk factor for the development of type 2 risk factor for the development of type 2 diabetes (Alberti, 1996) . Ryan diabetes (Alberti, 1996) . Ryan et al et al (2003) (2003) contrast the prevalence of impaired glucose contrast the prevalence of impaired glucose tolerance found in their study with that tolerance found in their study with that recently reported from a general population recently reported from a general population study in three regions of France (Gourdy study in three regions of France (Gourdy et et al al, 2001 ). The mean age of the Ryan cohort , 2001). The mean age of the Ryan cohort was 33 years, and the age-adjusted (35-64 was 33 years, and the age-adjusted (35-64 years) prevalence of impaired glucose toleryears) prevalence of impaired glucose tolerance found in the French study was 11.8% ance found in the French study was 11.8% in men and 5.2% in women. The prevain men and 5.2% in women. The prevalence of impaired glucose tolerance in the lence of impaired glucose tolerance in the population with schizo population with schizophrenia was therephrenia was therefore found to be twice that fore found to be twice that in a general in a general population (Ryan population (Ryan et al et al, 2003) . , 2003).
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Prevalence of diabetes Prevalence of diabetes in other psychiatric conditions in other psychiatric conditions
Schizophrenia is not the only severe mental Schizophrenia is not the only severe mental illness associated with an apparent increase illness associated with an apparent increase in the risk of diabetes. Regenold in the risk of diabetes. Regenold et al et al (2002) assessed the medical records of (2002) assessed the medical records of 243 in-patients, aged 50-74 years, with a 243 in-patients, aged 50-74 years, with a diagnosis of major depression, bipolar I diagnosis of major depression, bipolar I disorder, schizoaffective disorder, schizodisorder, schizoaffective disorder, schizophrenia or dementia, and compared their phrenia or dementia, and compared their rates of diabetes with rates in the US rates of diabetes with rates in the US general population matched for age, gender general population matched for age, gender and race. The prevalence of diabetes was and race. The prevalence of diabetes was found to be significantly higher than found to be significantly higher than national norms in patients with bipolar I national norms in patients with bipolar I disorder (26%) and schizoaffective disorder disorder (26%) and schizoaffective disorder (50%), and was independent of psycho-(50%), and was independent of psychotropic drug use (Regenold tropic drug use (Regenold et al et al, 2002) . This , 2002) . This study, and the work of others (Cassidy study, and the work of others (Cassidy et al et al, , 1999) , indicate that the prevalence of 1999), indicate that the prevalence of diabetes in patients with bipolar disorder diabetes in patients with bipolar disorder may be two to three times higher than that may be two to three times higher than that found in the general population. found in the general population.
Schizophrenia: an independent Schizophrenia: an independent risk factor for diabetes? risk factor for diabetes?
The interaction between diabetes and The interaction between diabetes and schizophrenia, although relatively well schizophrenia, although relatively well established, is far from simple. The mechestablished, is far from simple. The mechanisms behind the interaction are likely anisms behind the interaction are likely to be multifactorial, and to include genetic to be multifactorial, and to include genetic and environmental factors, as well as and environmental factors, as well as the possible effects of antipsychotic the possible effects of antipsychotic medications. medications.
Genetic factors Genetic factors
Genetic factors appear to have a key role in Genetic factors appear to have a key role in the association between schizophrenia and the association between schizophrenia and diabetes, since it has been reported that diabetes, since it has been reported that up to 50% of individuals with schizoup to 50% of individuals with schizophrenia have a family history of type 2 phrenia have a family history of type 2 diabetes, compared with just 4.6% of diabetes, compared with just 4.6% of healthy healthy adult controls (Dynes, 1969; adult controls (Dynes, 1969; Mukherjee Mukherjee et al et al 1989; Cheta 1989; Cheta et al et al, , 1990; Lamberti 1990; Lamberti et al et al, 2003; Shiloah , 2003; Shiloah et al et al, , 2003) . In one of the largest chart reviews 2003). In one of the largest chart reviews ever conducted of schizophrenia, Lamberti ever conducted of schizophrenia, Lamberti et al et al (2003) found a family history of type (2003) found a family history of type 2 diabetes in 17% of the total cohort of 2 diabetes in 17% of the total cohort of 436 patients. Importantly, in the cohort of 436 patients. Importantly, in the cohort of patients who had a positive family history patients who had a positive family history of diabetes, the prevalence of diabetes of diabetes, the prevalence of diabetes mellitus was 33%. In those with a negative mellitus was 33%. In those with a negative family history of diabetes, its prevalence family history of diabetes, its prevalence s 6 9 s 6 9 was just 10%. These data-sets suggest that was just 10%. These data-sets suggest that genetic factors may explain to some extent genetic factors may explain to some extent the higher diabetes prevalence figures found the higher diabetes prevalence figures found in patients with schizophrenia compared in patients with schizophrenia compared with the general population. with the general population.
Environmental factors Environmental factors
Many people with schizophrenia exhibit Many people with schizophrenia exhibit poor health behaviours that may also poor health behaviours that may also contribute to them developing diabetes; contribute to them developing diabetes; these include having less healthy diets (genthese include having less healthy diets (generally high in fat and low in fibre), exererally high in fat and low in fibre), exercising less and smoking more than normal cising less and smoking more than normal controls (Brown controls (Brown et al et al, 1999) . Poverty, un-, 1999) . Poverty, unstable living conditions and lower than stable living conditions and lower than expected educational attainment are all expected educational attainment are all associated with schizophrenia, and increase associated with schizophrenia, and increase the risk of obesity and other adverse the risk of obesity and other adverse medical sequelae (Dixon medical sequelae (Dixon et al et al, 2000) . Addi-, 2000) . Additional factors thought to predispose inditional factors thought to predispose individuals with schizophrenia to developing viduals with schizophrenia to developing diabetes include ethnicity, a history of diabetes include ethnicity, a history of glucose dysregulation, and pre-existing glucose dysregulation, and pre-existing hypertension (Lindenmayer hypertension (Lindenmayer et al et al, 2001) . , 2001). The role of antipsychotic medications The role of antipsychotic medications in the development of diabetes is far from in the development of diabetes is far from well defined. Evidence from studies published well defined. Evidence from studies published before the introduction of neuroleptic drugs before the introduction of neuroleptic drugs showed a strong association between severe showed a strong association between severe mental illness and abnormal glucose metamental illness and abnormal glucose metabolism (Kooy, 1919; Lorenz, 1922; Henry bolism (Kooy, 1919; Lorenz, 1922; Henry & Mangan, 1925; Freeman & Mangan, 1925; Freeman et al et al, 1944; , 1944; Freeman, 1946; Braceland Freeman, 1946; Braceland et al et al, 1945 Braceland et al et al, ), , 1945 , and although this evidence must be inand although this evidence must be interpreted with care because of the definiterpreted with care because of the definitions used in the studies, it suggests that tions used in the studies, it suggests that schizophrenia itself might be an indepenschizophrenia itself might be an independent risk factor for the development of dent risk factor for the development of diabetes. Reports of impaired glucose tolerdiabetes. Reports of impaired glucose tolerance in young, drug-naıve individuals with ance in young, drug-naïve individuals with first-episode schizophrenia (Ryan first-episode schizophrenia (Ryan et al et al, , 2003) add further weight to the argument 2003) add further weight to the argument that people with schizophrenia may be that people with schizophrenia may be naturally predisposed to developing dianaturally predisposed to developing diabetes, and should therefore be considered betes, and should therefore be considered to be a high-risk group. to be a high-risk group.
DISCUSSION DISCUSSION
People with schizophrenia and other People with schizophrenia and other serious psychiatric conditions appear to be serious psychiatric conditions appear to be at significant risk of developing impaired at significant risk of developing impaired glucose tolerance and diabetes, regardless glucose tolerance and diabetes, regardless of whether they are receiving antipsychotic of whether they are receiving antipsychotic medication. Many of these individuals at medication. Many of these individuals at risk are currently unrecognised. Cardiovasrisk are currently unrecognised. Cardiovascular risk factors such as diabetes, hypercular risk factors such as diabetes, hypertension and dyslipidaemia commonly tension and dyslipidaemia commonly coexist (Mukherjee coexist (Mukherjee et al et al, 1996) , so it seems , 1996), so it seems likely that these 'missing millions' of people likely that these 'missing millions' of people with impaired glucose tolerance and diawith impaired glucose tolerance and diabetes may also have comorbidities that betes may also have comorbidities that further increase their risk of cardiovascular further increase their risk of cardiovascular disease and premature death (Subramaniam disease and premature death (Subramaniam et al et al, 2003) . , 2003) . Natural causes are responsible for twoNatural causes are responsible for twothirds of the excess mortality associated thirds of the excess mortality associated with schizophrenia (Brown with schizophrenia (Brown et al et al, 2000) . In , 2000). In one record-linkage study, ischaemic heart one record-linkage study, ischaemic heart disease was found to be the most common disease was found to be the most common cause of death in both men and women cause of death in both men and women with schizophrenia (Herman with schizophrenia (Herman et al et al, 1983) . , 1983). Age, ethnic origin and geographical Age, ethnic origin and geographical location all appear to alter the prevalence location all appear to alter the prevalence of diabetes mellitus and impaired glucose of diabetes mellitus and impaired glucose tolerance. Early identification of these contolerance. Early identification of these conditions in high-risk groups is now a priority ditions in high-risk groups is now a priority in many countries. Diabetes UK currently in many countries. Diabetes UK currently recommends routine screening for diabetes recommends routine screening for diabetes in White people over the age of 40 years in White people over the age of 40 years and in people from Black, Asian and and in people from Black, Asian and minority ethnic groups aged over 25 years minority ethnic groups aged over 25 years if they have a first-degree family history of if they have a first-degree family history of diabetes, and/or are overweight and have diabetes, and/or are overweight and have a sedentary lifestyle, and/or have cardiovasa sedentary lifestyle, and/or have cardiovascular disease (Diabetes UK, 2002) . cular disease (Diabetes UK, 2002) .
The strength of the association between The strength of the association between schizophrenia and diabetes is such that timely schizophrenia and diabetes is such that timely screening and effective management of diascreening and effective management of diabetes risk factors in all our patients is now betes risk factors in all our patients is now recommended. Early detection of impaired recommended. Early detection of impaired glucose metabolism and effective education glucose metabolism and effective education about healthy living should help to reduce about healthy living should help to reduce the risk of patients developing the risk of patients developing diabetes diabetes and its complications, and may ultimately and its complications, and may ultimately help to improve long-term outcomes. help to improve long-term outcomes. Only large-scale, prospective, longitudinal studies in which all potential confounders are controlled for will establish the precise nature of the association. confounders are controlled for will establish the precise nature of the association. Alberti, K. G. (1996) Alberti, K. G. (1996) 
